Andrew Watson MD in Memphis, Tennessee

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Andrew Watson MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 6002857497
NPI #: 1033119474
NPI Created On: 07/28/2005
NPI Last Updated Listed as: 09/09/2019
Primary Taxonomy Code: 174400000X
License Number:
39793
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Ambetter
• Medicare

Languages spoken by staff include: English.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine ekg using at least 12 leads including interpretation and report
4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
7. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
9. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
10. Follow-up or limited ultrasound examination of heart
11. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
12. Ultrasound study of arteries and arterial grafts of both legs
13. New patient office or other outpatient visit, typically 30 minutes
14. New patient office or other outpatient visit, typically 45 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Initial hospital inpatient care, typically 30 minutes per day
17. Subsequent hospital inpatient care, typically 25 minutes per day
18. Technetium tc-99m tetrofosmin, diagnostic, per study dose
19. Injection, regadenoson, 0.1 mg